NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 0.94% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 0.93% |
| MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 0.91% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 0.87% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 0.86% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 0.85% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 0.84% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 0.83% |
| CDTX | Cidara Therapeutics Inc | Healthcare | Biotechnology | 0.82% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 0.82% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 0.81% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 0.81% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 0.80% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 0.79% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 0.79% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 0.79% |
| GRAL | GRAIL, LLC | Healthcare | Diagnostics & Research | 0.77% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 0.77% |